Romanian Journal of Medical and Dental Education Volum 9 Issue 5, 2020 PARTICULARITIES OF STOMATOLOGICAL THERAPY IN PATIENTS WITH CARDIO-VASCULAR PATHOLOGY-REVIEW

PARTICULARITIES OF STOMATOLOGICAL THERAPY IN PATIENTS WITH CARDIO-VASCULAR PATHOLOGY-REVIEW

Irina Grădinaru, Loredana Liliana Hurjui, Mihaela Mitrea, Raluca Jipu, Claudia Cristina Tarniceriu, Magda Ecaterina Antohe

Abstract

High prevalence of cardiovascular diseases in the general population, especially ischemic heart disease, leads to the idea that your dentist practitioner will face frequently in patients with cardiac pathology. Peacock and Carson have also shown that more than half of patients presented at a periodontology clinic had a significant personal pathological history, the most important being cardiovascular diseases and poly-drug allergies. Oral anticoagulant therapy is commonly used, to prevent various thromboembolic events, such as, for example, in patients with heart valve prostheses, heart failure, atrial fibrillation, patients with myocardial infarction or injury to vascular cerebral history or venous thromboembolism (pulmonary embolism and deep vein thrombosis). Tetracyclines, erythromycin, clarithromycin and metronidazole are contraindicated in patients with anticoagulant therapy, because these antibiotics can increase the checker prothrombin . In addition, paracetamol, broad-spectrum antibiotics, cloralhidratul and fluconazole can potentiate the effect of warfarin. Xerostomy is one of the most common oral side effect in patients treated for various cardiovascular diseases and if not transient can cause dental caries or progression. Therefore, an appropriate treatment of xerostomia should be prescribed by the dentist and it includes both the use of fluorides in dental office, and at home to prevent the destruction of tissues, antimicrobial and artificial saliva and course counseling and patient education.

Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download